NDC 0173-0715

ADVAIR HFA

Fluticasone Propionate And Salmeterol Xinafoate

ADVAIR HFA is a Respiratory (inhalation) Aerosol, Metered in the Human Prescription Drug category. It is labeled and distributed by Glaxosmithkline Llc. The primary component is Fluticasone Propionate; Salmeterol Xinafoate.

• Product ID: 0173-0715_296f1772-58d7-4742-abc6-4557165605b2
• NDC: 0173-0715
• Product Type: Human Prescription Drug
• Proprietary Name: ADVAIR HFA
• Generic Name: Fluticasone Propionate And Salmeterol Xinafoate
• Dosage Form: Aerosol, Metered
• Route of Administration: RESPIRATORY (INHALATION)
• Marketing Start Date: 2008-09-29
• Marketing Category: NDA / NDA
• Application Number: NDA021254
• Labeler Name: GlaxoSmithKline LLC
• Substance Name: FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
• Active Ingredient Strength: 45 ug/1; ug/1
• Pharm Classes: Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 0173-0715-20

1 INHALER in 1 CARTON (0173-0715-20) > 120 AEROSOL, METERED in 1 INHALER

• Marketing Start Date: 2008-09-29
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0173-0715-20 [00173071520]

ADVAIR HFA AEROSOL, METERED

• Marketing Category: NDA
• Application Number: NDA021254
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: GM
• Marketing Start Date: 2008-09-29

NDC 0173-0715-61 [00173071561]

ADVAIR HFA AEROSOL, METERED

• Marketing Category: NDA
• Application Number: NDA021254
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2008-09-29
• Marketing End Date: 2019-08-31

NDC 0173-0715-22 [00173071522]

ADVAIR HFA AEROSOL, METERED

• Marketing Category: NDA
• Application Number: NDA021254
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: GM
• Marketing Start Date: 2008-09-29

NDC 0173-0715-62 [00173071562]

ADVAIR HFA AEROSOL, METERED

• Marketing Category: NDA
• Application Number: NDA021254
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2009-08-21
• Marketing End Date: 2011-04-25

Drug Details

Active Ingredients

Ingredient	Strength
FLUTICASONE PROPIONATE	45 ug/1

OpenFDA Data

• SPL SET ID: dfaca6f9-3277-47b2-319d-1377917cb54c
• Manufacturer:
  • GlaxoSmithKline LLC
• UNII:
  • O2GMZ0LF5W
  • 6EW8Q962A5
• RxNorm Concept Unique ID - RxCUI:
  • 896244
  • 896236
  • 896267
  • 896239
  • 896272
  • 896273
  • 896271
  • 896245
  • 896231
  • 896243
  • 896237
  • 896235

Pharmacological Class

• Corticosteroid [EPC]
• Corticosteroid Hormone Receptor Agonists [MoA]
• Adrenergic beta2-Agonists [MoA]
• beta2-Adrenergic Agonist [EPC]

NDC Crossover Matching brand name "ADVAIR HFA" or generic name "Fluticasone Propionate And Salmeterol Xinafoate"

NDC	Brand Name	Generic Name
0173-0715	ADVAIR HFA	fluticasone propionate and salmeterol xinafoate
0173-0716	ADVAIR HFA	fluticasone propionate and salmeterol xinafoate
0173-0717	ADVAIR HFA	fluticasone propionate and salmeterol xinafoate